NICOLE BURROWS: Open Payments
NPI 1689612004 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 32 payments from 12 companies in 2025. Trend: 2023 $516 · 2024 $854 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $211 |
| ABBVIE INC. | 7 | $156 |
| PFIZER INC. | 5 | $106 |
| Janssen Biotech, Inc. | 2 | $62 |
| GlaxoSmithKline, LLC. | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Menarini Silicon Biosystems, Inc. | 1 | $38 |
| BeOne Medicines USA, Inc. | 1 | $35 |
| Lilly USA, LLC | 1 | $32 |
| Incyte Corporation | 1 | $23 |
Products named: LYNPARZA, KEYTRUDA, ELAHERE, TIVDAK, JEMPERLI, RYBREVANT, Cellsearch, BRUKINSA.
Industry payments across IL — which companies pay providers there.
